Imperial College London

Emeritus ProfessorCharlesPusey

Faculty of MedicineDepartment of Immunology and Inflammation

Emeritus Professor of Medicine
 
 
 
//

Contact

 

+44 (0)20 3313 2308c.pusey

 
 
//

Assistant

 

Miss Anjli Jagpal +44 (0)20 3313 3152

 
//

Location

 

9N4DCommonwealth BuildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Prendecki:2018:10.12688/f1000research.14626.1,
author = {Prendecki, M and Pusey, CD},
doi = {10.12688/f1000research.14626.1},
journal = {F1000Research},
title = {Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis [version 1; referees: 2 approved]},
url = {http://dx.doi.org/10.12688/f1000research.14626.1},
volume = {7},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - Anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitides (AAV) are rare systemic autoimmune diseases characterised by inflammation of small blood vessels. Recent developments have been made in our understanding of the pathogenesis of these diseases, including the pathogenic role of ANCA, neutrophils and monocytes as mediators of injury, dysregulation of the complement system, and the role of T and B cells. Current treatment strategies for AAV are based on broad immunosuppression, which may have significant side effects. Advances in understanding of the pathogenesis of disease have led to the identification of new therapeutic targets which may lead to treatment protocols with less-toxic side effects. The aim of this review is to summarise current information and recent advances in understanding of the pathogenesis of AAV.
AU - Prendecki,M
AU - Pusey,CD
DO - 10.12688/f1000research.14626.1
PY - 2018///
SN - 2046-1402
TI - Recent advances in understanding of the pathogenesis of ANCA-associated vasculitis [version 1; referees: 2 approved]
T2 - F1000Research
UR - http://dx.doi.org/10.12688/f1000research.14626.1
UR - https://www.ncbi.nlm.nih.gov/pubmed/30079228
UR - http://hdl.handle.net/10044/1/64736
VL - 7
ER -